Canada - Lipid Modifying Medicine Use
Since 2014, Canada Lipid Modifying Medicine Use rose 7.1% year on year. At 141.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, the country was ranked number 6 comparing other countries in Lipid Modifying Medicine Use. Canada is overtaken by Slovenia, which was ranked number 5 with 142 Units (Defined Daily Dosage) Per Thousand Persons Per Day and is followed by Australia with 141.2 Units (Defined Daily Dosage) Per Thousand Persons Per Day. Denmark topped the ranking with 159.5 Units (Defined Daily Dosage) Per Thousand Persons Per Day in 2019, that is a growth of 3.5% compared to 2018. United Kingdom, Norway and Belgium respectively ranked number 2, 3 and 4 in this ranking. Lithuania witnessed the best average annual growth at +18.8% per year, while Slovakia witnessed the worst performance at -8.7% per year.
Loading...
Date | Units (Defined Daily Dosage) Per Thousand Persons Per Day |
---|---|
2019 | 141.50 |
2018 | 130.10 |
2017 | 121.30 |
2016 | 117.40 |
2015 | 103.40 |
How does Canada rank in Lipid Modifying Medicine Use?
# | 28 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
Denmark
|
160 | 2019 | +3.5 % | +3.8 % | View data | |
2 |
#2
United Kingdom
|
153 | 2019 | +1.7 % | +2.3 % | View data | |
5 |
#5
Slovenia
|
142 | 2019 | +3.0 % | +4.8 % | View data | |
6 |
#6
Canada
|
142 | 2019 | +8.8 % | +7.1 % | View data | |
7 |
#7
Australia
|
141 | 2019 | +1.7 % | +1.4 % | View data |